These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Giaffer MH; Clark A; Holdsworth CD Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231 [TBL] [Abstract][Full Text] [Related]
23. Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease. Richens ER; Williams MJ; Gough KR; Ancill RJ Gut; 1974 Jan; 15(1):24-8. PubMed ID: 4274413 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre. Kocsis D; Tóth Z; Csontos ÁA; Miheller P; Pák P; Herszényi L; Tóth M; Tulassay Z; Juhász M BMC Gastroenterol; 2015 Oct; 15():141. PubMed ID: 26481725 [TBL] [Abstract][Full Text] [Related]
25. Antibodies against Mycobacterium paratuberculosis in Crohn's disease. Walmsley RS; Ibbotson JP; Chahal H; Allan RN QJM; 1996 Mar; 89(3):217-21. PubMed ID: 8731566 [TBL] [Abstract][Full Text] [Related]
26. Studies on the nature and significance of connective tissue antibodies in adult coeliac disease and Crohn's disease. Magalhaes AF; Peters TJ; Doe WF Gut; 1974 Apr; 15(4):284-8. PubMed ID: 4834553 [TBL] [Abstract][Full Text] [Related]
28. The genetics of chronic inflammatory diseases. Heap GA; van Heel DA Hum Mol Genet; 2009 Apr; 18(R1):R101-6. PubMed ID: 19297396 [TBL] [Abstract][Full Text] [Related]
29. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Di Tola M; Sabbatella L; Anania MC; Viscido A; Caprilli R; Pica R; Paoluzi P; Picarelli A Clin Chem Lab Med; 2004; 42(10):1092-7. PubMed ID: 15552265 [TBL] [Abstract][Full Text] [Related]
30. Unknown complicated celiac disease as an unexpected finding in patients investigated with capsule endoscopy for Crohn's disease. A case series. Ciobanu L; Pascu O; Iobagiu S; Damian D; Dumitru E; Tantau M J Gastrointestin Liver Dis; 2013 Mar; 22(1):97-100. PubMed ID: 23539398 [TBL] [Abstract][Full Text] [Related]
31. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease. Goodacre RL; Bienenstock J Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886 [TBL] [Abstract][Full Text] [Related]
32. Intestinal permeability in children with Crohn's disease and coeliac disease. Pearson AD; Eastham EJ; Laker MF; Craft AW; Nelson R Br Med J (Clin Res Ed); 1982 Jul; 285(6334):20-1. PubMed ID: 6805795 [TBL] [Abstract][Full Text] [Related]
33. Neutrophil-lymphocyte ratio in Crohn's disease patients predicts sustained response to infliximab 52-week therapy. Wlodarczyk MK; Sobolewska AE; Stec-Michalska K; Fichna JJ; Wisniewska-Jarosinska ME J Gastrointestin Liver Dis; 2015 Mar; 24(1):127-8. PubMed ID: 25822447 [No Abstract] [Full Text] [Related]
34. Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease. Leonard N; Hourihane DO; Whelan A Gut; 1995 Dec; 37(6):763-5. PubMed ID: 8537045 [TBL] [Abstract][Full Text] [Related]
35. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. Barta Z; Csípõ I; Szabó GG; Szegedi G World J Gastroenterol; 2003 Oct; 9(10):2308-12. PubMed ID: 14562398 [TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to gliadin-binding 90 kDa glycoprotein in coeliac disease. Maury CP; Teppo AM; Vuoristo M; Turunen U; Virtanen I Gut; 1986 Feb; 27(2):147-52. PubMed ID: 3485069 [TBL] [Abstract][Full Text] [Related]
37. Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease. Bartholo RM; Zaltman C; Elia C; Cardoso AP; Flores V; Lago P; Cassabian L; Dorileo FC; Lapa-e-Silva JR Braz J Med Biol Res; 2005 Feb; 38(2):197-203. PubMed ID: 15785830 [TBL] [Abstract][Full Text] [Related]